A Short Post-Reattachment Ultrasensitive Window of Time in Human Cancer Cells as Therapeutic Target of Prolonged Low-Dose Administration of Specific Compounds

<div>MTT assay. After incubating ~2,000 cells/well in 96-well culture plates overnight to adhere, H460 cells were exposed to increasing concentrations of (a) nigericin and (b) menadione. For MCF7, ~5,000 cells/well were plated in 96 well plates, allowed to adhere, and then exposed to (c) nigericin and (d) menadione. After 72 hours, the MTT assay was performed. This figure is representative of at least three independent experiments.</div>

International Journal of Cell Biology

fig2

Figure 2

Figure 2: A Short Post-Reattachment Ultrasensitive Window of Time in Human Cancer Cells as Therapeutic Target of Prolonged Low-Dose Administration of Specific Compounds 

Figure 2 | A Short Post-Reattachment Ultrasensitive Window of Time in Human Cancer Cells as Therapeutic Target of Prolonged Low-Dose Administration of Specific Compounds 